G6PD and ovarian cancer: G6PD is detected in the exosome and mediates metabolic transformation that accounts for tumor development in two late-stage ovarian cell lines, and it could act as a diagnostic, poor prognostic and therapeutic target of late-stage ovarian cancer [68] (Figure 6d).